Pharmacotherapy: A Pathophysiologic Approach

You are currently responding to the WTGOOG promotion.
If you wish to view a different promotion, please enter your Promotion Code here:

Great deals and more!

Sign up for special offers, exclusive discounts, and new product announcements from McGraw-Hill Professional.

SIGN UP TODAY

Related Subscription Sites



Date

June 15, 2008

Format

Electronic book text, 2784 pages

ISBN

0071643257 / 9780071643252

Adobe Digital Editions® is required to view your downloaded eBooks.
Click here to get Adobe Digital Editions
To learn more about eBooks please see our eBook FAQ.


If you're having problems installing due to firewall issues please go here:
http://kb2.adobe.com/cps/403/kb403051.html

$

Your Price

164.80

List Price

206.00



Overview


Main description

The benchmark evidence-based pharmacotherapy text-now in full color!

Additional chapters are available online

When it comes to helping you develop a mastery of evidence-based medicine for optimal patient outcomes, no book can match Pharmacotherapy: A Pathophysiologic Approach. Like the discipline it covers, the scope of this trusted resource goes beyond drug indications and dosages to include the initial selection, proper administration, and monitoring of drugs.

The book also delves into psychosocial issues that affect compliance … topics related to a patient's ability to understand and manage often-complex therapy… and lifestyle changes that may reduce the need for drug therapy or improve pharmacotherapeutic outcomes. Pharmacotherapy delivers everything you need to provide safe, efficacious drug therapy across the full range of therapeutic categories.

FEATURES

  • NEW! Expanded evidence-based recommendations
  • NEW! Extended coverage of the timely issue of palliative care and pain medicine
  • NEW! Important chapters on Pulmonary Hypertension, Disorders of Calcium and Phosphorus Homeostasis, and Multiple Myeloma,
  • Outstanding pedagogy, including:
  • “Key Concepts” highlighted in each chapter
  • “Clinical Presentation” boxes summarize the most common disease signs and symptoms covered in each chapter
  • “Clinical Controversies” boxes-presented in the Treatment sections of the disease-oriented chapters-examine the complicated issues faced by students and clinicians in providing drug therapy
  • Clear therapeutic recommendations in each disease-specific chapter
  • “Evaluation of Therapeutic Outcomes” boxes in each disease-specific chapter, containing key monitoring guidelines that facilitate the development of a pharmaceutical, nursing, or medical care plan


Author comments

Joseph T. DiPiro, PharmD, FCCP, Executive Dean, South Carolina School of Pharmacy, Charleston and Columbia, SC

Robert L. Talbert, PharmD, FCCP, BCPS Professor, University of Texas, Austin and University of Texas Health Science Center at San Antonio.

Gary C. Yee, PharmD, FCCP, Professor and Chair of Pharmacy Practice, University of Nebraska Medicial Center, Omaha

Gary R. Matzke, PharmD, FCP, FCCP Associate Dean for Clinical Research and Public Policy, Professor of Pharmacy and Medicine, Virginia Commonwealth University, Richmond, VA

Barbara G. Wells, PharmD, FASHP, FCCP, BCPP, Dean, University of Mississippi, Oxford, MS

L. Michael Posey, BS Pharm, President, PENS Pharmacy Editorial and News Service, Athens, GA





Copyright 2013 McGraw-Hill Global Education Holdings, LLC

WELCOME!

Before you can enjoy free downloads from McGraw-Hill Professional, we ask that you please provide your email address and country.



Yes, I want to receive other special offer.